Paper628199
[Drug treatment of primary hyperlipoproteinemia (author's transl)].
Klose G and 4 others. Klin Wochenschr, 1978. Cited by 13 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. [Drug treatment of primary hyperlipoproteinemia (author's transl)]. Papers, record 628199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/628199
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperlipidemias | Major topic |
| Anion Exchange Resins | |
| Biguanides | |
| Cholestyramine Resin | |
| Clofibrate | |
| Colestipol | |
| DEAE-Dextran | |
| Dextrothyroxine | |
| Drug Therapy, Combination | |
| Estrogens | |
| Humans | |
| Lipoproteins | |
| Neomycin | |
| Nicotinic Acids | |
| Progestins | |
| Sitosterols |
Source PubMed
References112
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,679,950 | Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment. | J Atheroscler Res | 1968 | https://conductscience.org/library/papers/5679950 | PubMed |
| 2 | 5,652,004 | Effect of nicotinic acid on catabolism and synthesis of cholesterol in man. | Clin Chim Acta | 1968 | https://conductscience.org/library/papers/5652004 | PubMed |
| 3 | 188,431 | Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters: its significance for the mechanism of lipid lowering by clofibrate and related drugs. | Atherosclerosis | 1976 | https://conductscience.org/library/papers/188431 | PubMed |
| 4 | 5,994,695 | [Treatment of hypercholesteremia with beta-pyridylcarbinol. I. Biochemistry and clinical results]. | Med Klin | 1966 | https://conductscience.org/library/papers/5994695 | PubMed |
| 5 | 4,357,927 | [Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)]. | Dtsch Med Wochenschr | 1973 | https://conductscience.org/library/papers/4357927 | PubMed |
| 6 | 4,126,562 | Portacaval shunt in hyperlipoproteinaemia. | Lancet | 1973 | https://conductscience.org/library/papers/4126562 | PubMed |
| 7 | 13,730,812 | Reductuon of serum-cholesterol by dextro-thyroxine in men with coronary heart-disease. | Lancet | 1961 | https://conductscience.org/library/papers/13730812 | PubMed |
| 8 | 4,562,098 | Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia. | JAMA | 1972 | https://conductscience.org/library/papers/4562098 | PubMed |
| 10 | 4,746,523 | Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycin. | Acta Med Scand | 1973 | https://conductscience.org/library/papers/4746523 | PubMed |
| 11 | 5,570,460 | Regulation of hepatic cholesterol biosynthesis by clofibrate administration. | J Pharmacol Exp Ther | 1971 | https://conductscience.org/library/papers/5570460 | PubMed |
| 12 | 5,470,476 | Precipitation by neomycin compounds of fatty acid and cholesterol from mixed micellar solutions. | Eur J Clin Invest | 1970 | https://conductscience.org/library/papers/5470476 | PubMed |
| 13 | 1,001,205 | [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)]. | Dtsch Med Wochenschr | 1976 | https://conductscience.org/library/papers/1001205 | PubMed |
| 14 | 5,764,121 | Measurements of cholesterol turnover, synthesis, and absorption in man, carried out by isotope kinetic and sterol balance methods. | J Lipid Res | 1969 | https://conductscience.org/library/papers/5764121 | PubMed |
| 15 | 971,343 | Treatment of hypercholesterolemia with Secholex. A long-term clinical trial and comparison with cholestyramine. | Atherosclerosis | 1976 | https://conductscience.org/library/papers/971343 | PubMed |
| 16 | 75,786 | [Mechanism of action of synthetic heparinoids: results in patients with hypertriglyceridaemia (author's transl)]. | Dtsch Med Wochenschr | 1978 | https://conductscience.org/library/papers/75786 | PubMed |
| 17 | 5,831,724 | Chemotherapy of hyperlipidemia. | Mayo Clin Proc | 1965 | https://conductscience.org/library/papers/5831724 | PubMed |
| 18 | 5,420,622 | Reduction of serum cholesterol and triglyceride levels by the combined administration of neomycin and clofibrate. | Circulation | 1970 | https://conductscience.org/library/papers/5420622 | PubMed |
| 19 | 4,982,663 | Hypolipidemic agents. | Prog Drug Res | 1969 | https://conductscience.org/library/papers/4982663 | PubMed |
| 20 | 1,101,545 | [Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation]. | Z Allgemeinmed | 1975 | https://conductscience.org/library/papers/1101545 | PubMed |
| 21 | 5,433,090 | Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and man. | Atherosclerosis | 1970 | https://conductscience.org/library/papers/5433090 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 6,876,687 | [Relation between serum lipoprotein metabolism and biliary lipid metabolism]. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6876687 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/628199
GET https://conductscience.org/api/papers/v1/628199/references?page=2